Log in
Enquire now
‌

US Patent 11873349 Compositions and methods related to IL27 receptor binding

Patent 11873349 was granted and assigned to Synthekine on January, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Synthekine
Synthekine
0
Current Assignee
Synthekine
Synthekine
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
118733490
Patent Inventor Names
Deepti Rokkam0
Patrick Lupardus0
Robert Kastelein0
Date of Patent
January 16, 2024
0
Patent Application Number
181643860
Date Filed
February 3, 2023
0
Patent Citations
‌
US Patent 10421807 Interleukin-31 monoclonal antibody
0
‌
US Patent 8258268 Dual variable domain immunoglobulin and uses thereof
0
‌
US Patent 8921528 Bispecific fusion antibodies with enhanced serum half-life
0
‌
US Patent 8975382 Amino acid sequences directed against HER2 and polypeptides comprising the same for the treatment of cancers and/or tumors
0
‌
US Patent 9334331 Bispecific antibodies
0
‌
US Patent 10927186 T cell recruiting polypeptides based on TCR alpha/beta reactivity
0
Patent Primary Examiner
‌
Lynn A Bristol
0
CPC Code
‌
C07K 2317/569
0
‌
C07K 2317/565
0
‌
C07K 2317/31
0
‌
C07K 16/468
0
Patent abstract

Provided herein are IL27R binding proteins that bind to IL27Rα and gp130 and comprise an anti-IL27Rα V

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11873349 Compositions and methods related to IL27 receptor binding

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.